Recap: Karyopharm Therapeutics Q1 Earnings


Karyopharm Therapeutics KPTI reported its Q1 earnings results on Thursday, May 4, 2023 at 07:45 AM.

Here's what investors need to know about the announcement.


Karyopharm Therapeutics beat estimated earnings by 18.92%, reporting an EPS of $-0.3 versus an estimate of $-0.37.

Revenue was down $8.97 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.08 which was followed by a 1.91% drop in the share price the next day.

Here's a look at Karyopharm Therapeutics's past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.35 -0.57 -0.63 -0.63
EPS Actual -0.43 -0.45 -0.62 -0.53
Revenue Estimate 35.12M 34.56M 35.59M 34.17M
Revenue Actual 33.58M 36.15M 39.68M 47.67M

To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsBZI-Recaps
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!